LJH685
LJH685 is a potent, ATP-competitive and selective RSK inhibitor, inhibits RSK1, 2, and 3 biochemical activities with IC50s of 6, 5, 4 nM, respectively[1].
Product Specifications
CAS Number
1627710-50-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Ribosomal S6 Kinase (RSK)
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LJH685.html
Concentration
10mM
Purity
99.64
Solubility
DMSO : ≥ 31 mg/mL
Smiles
OC1=C(F)C=C(C2=C(C3=CC=C(N4CCN(C)CC4)C=C3)C=CN=C2)C=C1F
Molecular Formula
C22H21F2N3O
Molecular Weight
381.42
Precautions
H302, H315, H319, H335
References & Citations
[1]Aronchik I, et al. Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers. Mol Cancer Res. 2014 May;12 (5) :803-12.|[2]Davies AH, et al. Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells. Oncotarget. 2015 Aug 21;6 (24) :20570-7.|[3]Jain R, et al. Discovery of Potent and Selective RSK Inhibitors as Biological Probes. J Med Chem. 2015 Sep 10;58 (17) :6766-83.|[4]My-My Huynh, et al. RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer. Expert Opin Ther Targets. 2020 Jan;24 (1) :1-5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRS012 100 µL
Alpha smooth muscle Actin Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
PKSM041298-01 10 µg
Recombinant Mouse OX40/TNFRSF4 Protein (Fc Tag)
Sign In for Pricing
View Details PKSM041298-02 50 µg
Recombinant Mouse OX40/TNFRSF4 Protein (Fc Tag)
Sign In for Pricing
View Details